Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, Cieslak PR, Hadler J, Farley MM, Facklam RR, Zell ER, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network.

JAMA. 2004 May 12;291(18):2197-203.

PMID:
15138241
2.

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.

JAMA. 2001 Apr 4;285(13):1729-35.

PMID:
11277827
3.

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.

PMID:
15665705
4.

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A.

JAMA. 2007 Apr 25;297(16):1784-92.

PMID:
17456820
5.

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

JAMA. 2005 Oct 26;294(16):2043-51.

PMID:
16249418
6.
7.

Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.

Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR.

Pediatr Infect Dis J. 2004 Aug;23(8):726-31.

PMID:
15295222
8.

Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine.

Spicer JO, Thomas S, Holst A, Baughman W, Farley MM.

Pediatr Infect Dis J. 2014 Feb;33(2):158-64. doi: 10.1097/INF.0000000000000025.

PMID:
24418837
9.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
10.

Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.

Wortham JM, Zell ER, Pondo T, Harrison LH, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett NM, Petit S, Aragon D, Bareta J, Juni BA, Farley MM, Beall B, Moore MR.

Clin Infect Dis. 2014 May;58(9):1250-7. doi: 10.1093/cid/ciu108. Epub 2014 Feb 27.

PMID:
24585565
11.

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W.

JAMA. 2006 Apr 12;295(14):1668-74.

PMID:
16609088
12.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
13.

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ.

Pediatrics. 2004 Mar;113(3 Pt 1):443-9.

PMID:
14993532
14.

Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.

Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr; U.S. Pediatric Multicenter Pneumococcal Surveillance Group.

Pediatr Infect Dis J. 2006 Apr;25(4):301-5.

PMID:
16567980
15.

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE.

Pediatr Infect Dis J. 2005 Apr;24(4):320-3.

PMID:
15818291
16.

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.

Mera R, Miller LA, Fritsche TR, Jones RN.

Microb Drug Resist. 2008 Jun;14(2):101-7. doi: 10.1089/mdr.2008.0782.

PMID:
18491947
17.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087. Epub 2008 Apr 18.

PMID:
18456376
18.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.

PMID:
15194827
19.

Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy.

Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A.

Arch Intern Med. 2000 Jan 10;160(1):89-94.

PMID:
10632309
20.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490

Supplemental Content

Support Center